Radiation Therapy Outreach Program for Minority or Low-Income Patients With Newly Diagnosed Cancer
NCT ID: NCT00400699
Last Updated: 2014-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
3150 participants
INTERVENTIONAL
2004-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This clinical trial is studying how well a radiation therapy outreach program works in minority or low-income patients with newly diagnosed cancer.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Educational Program in Younger Women Who Have Recently Finished Treatment for Stage I or Stage II Breast Cancer
NCT00416572
Intervention for Rural Cancer Patients
NCT05091593
Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions
NCT00891969
Accountability for Cancer Care Through Undoing Racism and Equity
NCT01954641
Fear of Recurrence and Stopping Immunotherapy
NCT04761328
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Develop, over five years, and implement a shared infrastructure that will permit participating community cancer centers to participate in radiation oncology clinical research and dramatically increase their rate of trial accrual above historical patterns.
* Increase access to radiation oncology services and clinical trials for underserved minority and/or low-income patients in the target areas, through community and professional education and outreach activities.
* Assess and ensure the quality of radiation oncology services at participating facilities through the use of a new integrated radiation oncology outcomes database and a quality assurance program, benchmarking daily practice patterns to clinical practice protocol.
* Compare treatment approaches and outcomes for cervical, colorectal, lung, prostate, breast, and head and neck cancers across racial and socioeconomic status groups.
* Conduct community intervention pilot programs that advance the understanding of factors that lead to health disparities.
* Develop and implement clinical treatment studies that attempt to reduce or eliminate health disparities through novel treatment approaches.
* Develop and refine a model program that can be sustained by the community treatment facilities long after study completion, and that the National Cancer Institute or other similarly motivated funders can replicate within other regions.
OUTLINE: This is a multicenter study.
Patients are enrolled in the Patient Navigator program, an initiative to promote equal access and quality of cancer care. Patients undergo an interview with the Patient Navigator, who is an oncology health professional, over approximately 1 hour to identify specific needs, in terms of receiving cancer care. The interview serves as a basis for developing a plan to assist patients through treatment and follow up. The Patient Navigator meets the patient, in person or over the phone, at various times during treatment to help the patient overcome barriers to completion of cancer therapy. The Patient Navigator then provides yearly follow up to facilitate continued medical follow up. Patients complete surveys before and after program participation.
Patients are followed periodically to determine their current status in cancer therapy.
TELESYNERGY®, a portable live-time interactive telemedicine system, is utilized in developing the necessary infrastructure and professional education in the community. It is used for sharing information and approaches for case presentation, treatment planning conferences, and other specialized presentations by invited speakers and expert panels. Activities using the TELESYNERGY® system are videotaped to create a library of topic-centered presentations that can be shared with the larger community. Components and summaries are placed on an Internet site to encourage communication with the larger oncology community.
PROJECTED ACCRUAL: A total of 3,150 patients will be accrued for this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
REview
counseling intervention
study of socioeconomic and demographic variables
psychosocial assessment and care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
counseling intervention
study of socioeconomic and demographic variables
psychosocial assessment and care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Newly diagnosed cancer
* Receiving radiation therapy and/or chemotherapy
* Minority and/or economically disadvantaged population
PATIENT CHARACTERISTICS:
* Within any of the following service areas of 5 different hospitals in western Pennsylvania:
* New Castle
* Pittsburgh Metro
* Somerset
* Mckeesport
* Johnstown
* Any race, ethnicity, gender, or HIV status allowed
* HIV serostatus is not evaluated specifically for study participation
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of Pittsburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dwight Heron
MD, FACRO, FACR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dwight E. Heron, MD
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UPMC Cancer Center at UPMC McKeesport
McKeesport, Pennsylvania, United States
UPMC Cancer Center - New Castle
New Castle, Pennsylvania, United States
Mercy Cancer Institute at Mercy Hospital
Pittsburgh, Pennsylvania, United States
Somerset Oncology Center
Somerset, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDR0000513067
Identifier Type: REGISTRY
Identifier Source: secondary_id
PCI-0408108
Identifier Type: -
Identifier Source: org_study_id
NCT00304343
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.